Paris, France and Camberley, UK – 7 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update following the launch of its research use only (RUO) test for novel coronavirus (2019-nCoV), which has been developed by its subsidiary Primerdesign as a direct response to the recent outbreak
Visit PageNews and Events
Information mensuelle le contrat de liquidité et sur le nombre total de droits de vote
Paris, France et Camberley, Royaume-Uni – 3 février 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat de liquidité confié à Invest Securities SA (le « Contrat de liquidité »). Le contrat de liquidité est régi par le droit français
Visit PageLiquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 3 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit Page